Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron.

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Abstract Text:

M Itou,S Kishimoto,H Kawata,M Ozaki,H Sakurai,F Itoh,

The design and performance of a new spectrometer for coincidence measurements between the Compton scattered photon and the recoil electron are described. Coincidence measurements give direct information on the three-dimensional electron momentum density (EMD) of condensed matter. The present spectrometer measures energy spectra of both the photon and the electron. The energy spectrum of electrons is measured by a time-of-flight method using single-bunch operation at the Photon Factory Accumulator Ring (PF-AR). The energy resolution obtained for the recoil electron is 190 eV, which is better than that of the photon detector, so that a momentum resolution of the three-dimensional EMD of 0.3 atomic units can be achieved.

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Publishing Authors By Initials

M Itou,S Kishimoto,H Kawata,M Ozaki,H Sakurai,F Itoh,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of synchrotron radiation

VOLUME: 5

Page Numbers: 676-8

Journal Abbreviation:

ISSN: 0909-0495

DAY: 1

MONTH: 05

YEAR: 1998

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9888878

Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron.

AFFILIATION: Department of Synchrotron Radiation Science, The Graduate University for Advanced Studies, 1-1 Oho, Tsukuba, Ibaraki 305-0801, Japan.

Country: Denmark

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Synchrotron Radiat

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Development of an X, eX spectrometer for measuring the energies of the scattered photon and recoil electron Related Publications

• A novel anti-rheumatic drug, T-614, stimulates osteoblastic differentiation in vitro and bone morphogenetic protein-2-induced bone formation in vivo.
• Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts.
• Brorin, a novel secreted bone morphogenetic protein antagonist, promotes neurogenesis in mouse neural precursor cells.
• Combined system of synchrotron radiation and laser for solid-state research.
• Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix.
• Deterministic design of binary phase-only blazed grating with subwavelength features under limitation on spatial resolution of fabrication technique.
• Development of an (X, eX) spectrometer for measuring the energies of the scattered photon and recoil electron.
• Difficulties in the diagnosis of appendicitis: review of CT and US images.
• Disorders of cardiac repolarization.
• Evaluation of Quantitative Portal Venous, Hepatic Arterial, and Total Hepatic Tissue Blood Flow Using Xenon CT in Alcoholic Liver Cirrhosis: Comparison With Liver Cirrhosis C.
• Factors influencing subjective sleepiness in patients with obstructive sleep apnea syndrome.
• Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b(+) HLA-A24(+) patients.
• Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b(+) HLA-A24(+) patients.
• Imaging by multiple modalities of patients with a carotidynia syndrome.
• In vitro production of bilirubin photoisomers by light irradiation using neoBLUE.
• Induction of twinning in crossbred heifers by ipsilateral frozen embryo transfer.
• Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: an autopsy report.
• Nicorandil attenuates reperfusion injury after long cardioplegic arrest.
• Phylogenetic Analysis of Isolates of Pasteurella pneumotropica from Laboratory Animals Based on the gyrB Gene Sequence.
• Production of shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro.
• Rapid genotyping of the Ser447Stop variant of the lipoprotein lipase gene using real-time fluorescent PCR.
• Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity.
• Segmented chirped grating for coarse wavelength division demultiplexing with multimode optical fibers.
• Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats.
• Sources of variation and reference intervals for serum cystatin C in a healthy Japanese adult population.
• Subclinical Hypothyroidism is Related to Lower Heel QUS in Postmenopausal Women.
• Tandem reductive perfluoroalkylation of esters with perfluoroalkyl titanate-type reagents.
• The (pro)renin receptor and the kidney.
• Xenon computed tomography shows hemodynamic change during the progression of chronic hepatitis C.
• [Pharmacological profile and clinical efficacy of olopatadine hydrochloride ophthalmic solution (Patanol 0.1% ophthalmic solution)]